Thorough assessment of 3’,4’-Methylenedioxy-α-pyrrolidinohexiophenone (MDPHP; ‘Monkey Dust’) and other synthetic cathinones under the Misuse of Drugs Act 1971. Provides robust arguments for why reclassification to Class A was not recommended.
Prof Harry Sumnall
JUST PUBLISHED: ACMD advice on synthetic cathinones www.gov.uk/government/p...
ACMD has written an updated harms assessment describing the use and harms of synthetic cathinones following a government commission.
